| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/14/2008 | WO2008039087A3 Indoline derivatives and uses thereof |
| 08/14/2008 | WO2008010984A3 Acridine activation of p53 and uses thereof |
| 08/14/2008 | US20080194839 Synthesis of porphyrins designed for attachment to electroactive surfaces via one or more carbon tethers |
| 08/14/2008 | US20080194661 1-(5-(4-trifluoromethyl-benzylamino)-1H-indazol-1-yl)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol; 2-(2,4-difluorophenyl)-1-(1H-indazol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
| 08/14/2008 | US20080194627 Aryl substituted pyridines and the use thereof |
| 08/14/2008 | US20080194617 Fused ring compound |
| 08/14/2008 | US20080194607 Modulation of pathogenicity |
| 08/14/2008 | US20080194606 Pyrazolyl-Amino-Substituted Pyrimidines and Their Use in the Treatment of Cancer |
| 08/14/2008 | US20080194597 Platelet adp receptor inhibitors |
| 08/14/2008 | US20080194588 Modulation of pathogcnicity |
| 08/14/2008 | US20080194585 Fungicidal Pyrazine Derivatives |
| 08/14/2008 | US20080194583 Tubulin Inhibitors |
| 08/14/2008 | US20080194582 3,5-Diphenyl-4,5-dihydro-1H-dipyrazole derivatives such as {2-[1-acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl]ethyl}(dimethyl)silanol that are useful for treating cancer |
| 08/14/2008 | US20080194581 Pyrrole derivatives, intermediates therefor, preparation and therapeutic use thereof |
| 08/14/2008 | US20080194578 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 08/14/2008 | US20080194577 Antiallergens; asthma; autoimmune disease; pruritius; antiarthritic agents |
| 08/14/2008 | US20080194576 Pyrimidine Derivatives and Their Use as P2Y12 Receptor Antagonists |
| 08/14/2008 | US20080194574 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases |
| 08/14/2008 | US20080194565 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases |
| 08/14/2008 | US20080194556 Quinazolines and Their Use as Aurora Kinase Inhibitors |
| 08/14/2008 | US20080194549 Organic Compounds |
| 08/14/2008 | US20080194545 Antimicrobial compositions and methods of use |
| 08/14/2008 | US20080194539 Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 Antagonists |
| 08/14/2008 | US20080193411 Anti-viral Compounds |
| 08/14/2008 | US20080193384 having chemical exchange saturation transfer (CEST)-active paramagnetic complexes linked to carriers selected from liposomes, particles, micelles and polypropylenimine dendrimers, used for mapping local pH, temperature, oxygen concentration or metabolites, detection of cancer lesions and inflammation |
| 08/14/2008 | CA2677995A1 Acylguanidine derivative |
| 08/14/2008 | CA2677661A1 Tricyclic compounds |
| 08/14/2008 | CA2677481A1 Triazole compounds that modulate hsp90 activity |
| 08/14/2008 | CA2677241A1 Compounds that inhibit cholinesterase |
| 08/14/2008 | CA2677015A1 Hcv inhibiting macrocyclic phenylcarbamates |
| 08/14/2008 | CA2676268A1 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 08/13/2008 | EP1956008A1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device |
| 08/13/2008 | EP1955697A1 2-aminobenzamide derivative |
| 08/13/2008 | EP1954692A1 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 08/13/2008 | EP1954682A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia |
| 08/13/2008 | EP1954673A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia |
| 08/13/2008 | EP1954317A2 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 08/13/2008 | EP1954276A2 Indole orexin receptor antagonists |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | CN101243075A Novel 2,3-dihydroindole compounds |
| 08/13/2008 | CN101243071A Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 08/13/2008 | CN101243070A Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 08/13/2008 | CN101243068A Compounds for the treatment of multi-drug resistant bacterial infections |
| 08/13/2008 | CN101243055A Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors |
| 08/13/2008 | CN101243052A Helix 12 directed non-steroidal antiandrogens |
| 08/13/2008 | CN101242848A Pyrimidine compounds |
| 08/13/2008 | CN101242844A Aminopyrimidines as kinase modulators |
| 08/13/2008 | CN101242843A Aminopyrimidines as kinase modulators |
| 08/13/2008 | CN101242834A Inhibitors of AKT activity |
| 08/13/2008 | CN101239975A Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl-1,3-diazaspirol[4,4]-non-ene-4-one |
| 08/13/2008 | CN101239974A Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl-1,3-diazaspirol[4,4]-non-ene-4-one |
| 08/13/2008 | CN101239972A Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 08/13/2008 | CN101239930A Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl-1,3-diazaspirol[4,4]-non-ene-4-one |
| 08/13/2008 | CN100410253C Highly effective environment friendly triazine amino stilbene fluorescent bleachng agent |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/12/2008 | US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives |
| 08/12/2008 | US7411073 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411065 Peptide nucleic acid monomers: diphenylmethyl, benzyl, alkylthioalkyl, or phenylthioalkyl esters of N-(1-[4-(2-benzothiazolyl-, 2-benzoxazolyl-, 2-benzofuranyl- or 2-benzothiophenyl-sulfonyl)-3-piperazinon-1-ylcarbonylmethyl]pyrimidon-4-yl)carbamic acids |
| 08/12/2008 | US7410989 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2-[5(6)-Amidino-2-benzimidazoyl]-5-(4-nitrophenyl)furan |
| 08/12/2008 | US7410972 Compounds |
| 08/12/2008 | US7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2008 | US7410968 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 08/12/2008 | CA2420461C Preparations for oral administration |
| 08/07/2008 | WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| 08/07/2008 | WO2008093639A1 Pyrazole compound |
| 08/07/2008 | WO2008092844A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
| 08/07/2008 | WO2008092231A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/07/2008 | WO2008092199A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | WO2008061792A3 Tricarbonyl complexes with tridentate chelators for myocardium imaging |
| 08/07/2008 | WO2008054748A3 Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/07/2008 | WO2007138351A3 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/07/2008 | US20080188655 Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof |
| 08/07/2008 | US20080188652 Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid |
| 08/07/2008 | US20080188536 2-thiophenecarboxylic acid-5-nitro-2-(2-thienylcarbonyl)hydrazide; antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial setting; bacterial damage or disease; Pseudomonas aeruginosa or Burkholderia cepacia |
| 08/07/2008 | US20080188535 2-thiophenecarboxylic acid-5-nitro-2-(2-thienylcarbonyl)hydrazide; antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial setting; bacterial damage or disease; Pseudomonas aeruginosa or Burkholderia cepacia |
| 08/07/2008 | US20080188521 Novel pharmaceutical compounds |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188491 Modulation of pathogenicity |
| 08/07/2008 | US20080188487 5-amido-(1h-indol-2-yl)-piperazin-1-yl-methanone derivatives |
| 08/07/2008 | US20080188474 Substituted triazoles useful as axl inhibitors |
| 08/07/2008 | US20080188472 Indole-2-Carboxylic Acid Hydrazides |
| 08/07/2008 | US20080188454 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine |
| 08/07/2008 | US20080188452 Macrocyclic Benzofused Pyrimidine Derivatives |
| 08/07/2008 | US20080188451 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol1yl)-3-(trifluoromethyl)phenyl]benzamide or an N-oxide or salts; anticarcinogenic agent (leukaemia) |
| 08/07/2008 | US20080187978 Anti-inflammatory medicaments |
| 08/07/2008 | US20080187575 Pyrimidine Derivatives |
| 08/07/2008 | CA2702647A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | CA2676984A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/07/2008 | CA2675348A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
| 08/06/2008 | EP1953152A1 Process for preparing quinazoline RHO-kinase inhibitors and intermediates thereof |
| 08/06/2008 | EP1953148A1 Heterocyclic amide compound and use thereof |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1953146A1 Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl) amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form |
| 08/06/2008 | EP1953145A1 Heterocyclic compound having inhibitory activity on 11- -hydroxysteroid dehydrogenase type i |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1951716A1 Aminopyrimidines useful as kinase inhibitors |